rs1165981822

Variant summary

Our verdict is Likely benign. The variant received -3 ACMG points: 1P and 4B. PP3BS2

The NM_005391.5(PDK3):​c.562G>A​(p.Asp188Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000015 in 1,202,287 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 8 hemizygotes in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.000018 ( 0 hom., 2 hem., cov: 23)
Exomes 𝑓: 0.000015 ( 0 hom. 6 hem. )

Consequence

PDK3
NM_005391.5 missense

Scores

3
6
8

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 9.93

Publications

0 publications found
Variant links:
Genes affected
PDK3 (HGNC:8811): (pyruvate dehydrogenase kinase 3) The pyruvate dehydrogenase (PDH) complex is a nuclear-encoded mitochondrial multienzyme complex that catalyzes the overall conversion of pyruvate to acetyl-CoA and CO(2). It provides the primary link between glycolysis and the tricarboxylic acid (TCA) cycle, and thus is one of the major enzymes responsible for the regulation of glucose metabolism. The enzymatic activity of PDH is regulated by a phosphorylation/dephosphorylation cycle, and phosphorylation results in inactivation of PDH. The protein encoded by this gene is one of the three pyruvate dehydrogenase kinases that inhibits the PDH complex by phosphorylation of the E1 alpha subunit. This gene is predominantly expressed in the heart and skeletal muscles. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2010]
PDK3 Gene-Disease associations (from GenCC):
  • Charcot-Marie-Tooth disease X-linked dominant 6
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -3 ACMG points.

PP3
MetaRNN computational evidence supports a deleterious effect, 0.817
BS2
High Hemizygotes in GnomAd4 at 2 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PDK3NM_005391.5 linkc.562G>A p.Asp188Asn missense_variant Exon 5 of 11 ENST00000379162.9 NP_005382.1
PDK3NM_001142386.3 linkc.562G>A p.Asp188Asn missense_variant Exon 5 of 12 NP_001135858.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PDK3ENST00000379162.9 linkc.562G>A p.Asp188Asn missense_variant Exon 5 of 11 1 NM_005391.5 ENSP00000368460.4
PDK3ENST00000568479.2 linkc.562G>A p.Asp188Asn missense_variant Exon 5 of 12 6 ENSP00000498864.1
PDK3ENST00000648777.1 linkn.562G>A non_coding_transcript_exon_variant Exon 5 of 12 ENSP00000497727.1

Frequencies

GnomAD3 genomes
AF:
0.0000179
AC:
2
AN:
111576
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.0000652
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00
AC:
0
AN:
180075
AF XY:
0.00
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000147
AC:
16
AN:
1090711
Hom.:
0
Cov.:
26
AF XY:
0.0000168
AC XY:
6
AN XY:
356323
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26219
American (AMR)
AF:
0.00
AC:
0
AN:
35063
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19307
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30032
South Asian (SAS)
AF:
0.00
AC:
0
AN:
53711
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40480
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4103
European-Non Finnish (NFE)
AF:
0.0000191
AC:
16
AN:
835953
Other (OTH)
AF:
0.00
AC:
0
AN:
45843
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.445
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000179
AC:
2
AN:
111576
Hom.:
0
Cov.:
23
AF XY:
0.0000592
AC XY:
2
AN XY:
33776
show subpopulations
African (AFR)
AF:
0.0000652
AC:
2
AN:
30658
American (AMR)
AF:
0.00
AC:
0
AN:
10461
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2647
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3574
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2686
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5980
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
238
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
53156
Other (OTH)
AF:
0.00
AC:
0
AN:
1493
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Uncertain:1
Apr 29, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.562G>A (p.D188N) alteration is located in exon 5 (coding exon 5) of the PDK3 gene. This alteration results from a G to A substitution at nucleotide position 562, causing the aspartic acid (D) at amino acid position 188 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Charcot-Marie-Tooth disease X-linked dominant 6 Uncertain:1
Sep 02, 2021
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces aspartic acid with asparagine at codon 188 of the PDK3 protein (p.Asp188Asn). The aspartic acid residue is highly conserved and there is a small physicochemical difference between aspartic acid and asparagine. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals affected with PDK3-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.49
BayesDel_addAF
Benign
-0.23
T
BayesDel_noAF
Benign
-0.57
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Benign
0.20
T;.
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.88
.;D
M_CAP
Pathogenic
0.52
D
MetaRNN
Pathogenic
0.82
D;D
MetaSVM
Benign
-1.1
T
MutationAssessor
Uncertain
2.1
M;M
PhyloP100
9.9
PrimateAI
Uncertain
0.78
T
PROVEAN
Uncertain
-3.2
D;D
REVEL
Benign
0.20
Sift
Benign
0.15
T;T
Sift4G
Benign
0.33
T;T
Polyphen
0.83
P;.
Vest4
0.66
MutPred
0.57
Gain of glycosylation at T190 (P = 0.1466);Gain of glycosylation at T190 (P = 0.1466);
MVP
0.72
MPC
1.4
ClinPred
0.97
D
GERP RS
5.6
Varity_R
0.77
Mutation Taster
=55/45
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1165981822; hg19: chrX-24523382; API